METHUSELAH ARCHIVE PRACTITIONERS / ALEKSANDR BOGOMOLETS
Black-and-white studio portrait of a young Alexander Bogomolets in early-twentieth-century formal dress, seated, facing slightly to the side.
PUBLIC DOMAIN source

Aleksandr Bogomolets

individual · Kyiv, Ukrainian SSR (Institute of Experimental Biology and Pathology; later Institute of Clinical Physiology, Academy of Sciences of the Ukrainian SSR)
lived:1881–1946
active:1934–1946
type:individual
role:promoter
location:Kyiv, Ukrainian SSR (Institute of Experimental Biology and Pathology; later Institute of Clinical Physiology, Academy of Sciences of the Ukrainian SSR)
eventual status:publicly_disconfirmed
FINANCIAL CONFLICTS
Bogomolets directed the Kyiv institute that produced antireticular cytotoxic serum, authored the connective-tissue theory that justified its use, wrote the English-language monograph that gave the theory and the serum their popular framing (*The Prolongation of Life*, Duell, Sloan and Pearce, 1946), and ran the academic apparatus (President of the Academy of Sciences of the Ukrainian SSR from 1930 until his death in 1946) through which the serum was distributed across Soviet medicine. The conflict of interest is structural rather than purely commercial: the developer, the credentialing authority within Ukrainian and Soviet science, and the principal scientific advocate for the serum were the same person, and the state-sponsored promotion of the work substituted political endorsement for independent controlled evaluation. Bogomolets did not publish controlled trial data on the serum; he did not publish formal conflict-of-interest disclosures with his clinical or theoretical accounts. The political-scientific concentration of roles is reconstructible from his institutional positions and his own monograph rather than from any disclosure he authored.
INTERVENTIONS PROMOTED
EXTERNAL REFERENCES
NOTES

Aleksandr Aleksandrovich Bogomolets (24 May 1881 to 19 July 1946) was a Soviet and Ukrainian pathophysiologist whose Kyiv institute developed antireticular cytotoxic serum (ACS) in the 1930s on the connective-tissue theory of aging. The Frank and Knopov 2021 retrospective in Arkhiv Patologii (PMID 33822557) and the 1956 Neiman memorial in the same journal (PMID 13382647) are two PubMed-indexed Russian-language biographical anchors for the 1881-1946 dates and the institutional placement of the work. Bogomolets gave the connective-tissue theory and the serum their definitive English-language statement in The Prolongation of Life (Duell, Sloan and Pearce, 1946), the year of his death. According to Joe Schwarcz’s 20 September 2024 synthesis at the McGill Office for Science and Society (first published in The Montreal Gazette), Stalin ‘appointed Bogomolets director of the Institute of Clinical Physiology in Kyiv, where ACS was subsequently produced for wide distribution in the Soviet Union’ and ‘is said to have gotten shots of it from time to time’; Bogomolets himself died at age 65, short of his stated longevity target of ‘past a hundred, maybe even as long as a 150’. The Schwarcz article does not give a cause of death and does not contain a Stalin remark on Bogomolets’s death; this bundle therefore makes no claim about either. Interest in ACS waned in the late 1940s after, in Schwarcz’s account, a grant to Harry Goldblatt (McGill MD 1916) supported a review of ACS in 3,500 patients that concluded the serum ‘is not a cure for anything’. Bogomolets’s later reputation in Ukraine remains as the founder of the Bogomolets Institute of Physiology in Kyiv and the namesake of the medical university there; the specific serum no longer figures in mainstream therapeutic practice.